A

Alto Neuroscience
D

ANRO

2.24000
USD
-0.02
(-0.93%)
مغلق
حجم التداول
5,460
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
60,641,569
المقالات

العنوان: Alto Neuroscience

القطاع: Healthcare
الصناعة: Biotechnology
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.